Therapeutic objectives and their practical achievement in type 2 diabetes

Journal of Diabetes and its Complications

Volumn 14, Issue 4, 2000, Pages 180-184

  Keen, Harry ^a  

^a Unit for Metabolic Medicine   (United Kingdom)

Author keywords

Complications; Macrovascular; Microvascular; Type 2 diabetes

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA LINOLENIC ACID;

COMPLICATION; CONFERENCE PAPER; DIABETIC ANGIOPATHY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LIPIDS; MALE; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 0033811072     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(00)00085-4     Document Type: Conference Paper

References (15)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.
2. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: the World Health Organization multinational study of vascular disease in diabetes. Diabetologia. 28:1985;615-640. (suppl).
3. Guidelines for diabetes care. Diabetes Med. 16:1999;716-730.
4. Gall M.-A., Nielsen F.S., Smidt U.M., Parving H.-H. The course of kidney function in type 2 (non-insulin dependent) diabetic patients with diabetic nephropathy. Diabetologia. 36:1993;1071-1078.
5. Gruber W., Lander T., Leese B., Songer T., Williams R. A Report of a Diabetes Health Economics Study Group. The Economics of Diabetes and Diabetes Care. 1999;World Health Organisation, NCD, Geneva. International Diabetes Federation, Brussels.
6. Hales C.N., Barker D.J.P. Type 2 (non-insulin-dependent) diabetes mellitus. The thrifty phenotype hypothesis. Diabetologia. 35:1992;595-601.
7. Keen H., Clark C., Laakso M. Reducing the burden of diabetes: managing cardiovascular disease. Diabetes Metab Res Rev. 15:1999;186-196.
8. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 18:1995;258-268.
9. Knowler W.C., McCance D.R., Nagi D.K., Pettit D.J. Epidemiological studies of the causes of non-insulin-dependent diabetes mellitus. Leslie R.D.G. Causes of Diabetes. 1993;187-218 John Wiley & Sons, Chichester, England.
10. Krans H.M.J., Porta M., Keen H., Staehr Johansen K. Diabetes Care and Research in Europe: The St. Vincent Declaration Action Programme. 2nd edn. 1995;WHO Regional Office for Europe, Copenhagen.
11. Scheuner M.T., Raffel L.J., Rotter J.I. Genetics of diabetes. Alberti K.G.M.M., Zimmet P., DeFronzo R.A., Keen H. International Textbook of Diabetes Mellitus. 2nd edn. 1997;55-74 John Wiley & Sons, Chichester, England.
12. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16:1993;434-444.
13. Stephenson J.M., Kenny S., Stevens L.K., Fuller J.H., Lee E. Proteinuria and mortality in diabetes: the WHO multinational study of vascular disease in diabetes. Diabetes Med. 12:1995;149-155.
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
15. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). Br Med J. 317:1998;703-713.